A new report from the Congressional Research Service provides a comprehensive overview of government efforts to combat money-laundering, discussing the scope of the money-laundering problem, the strategies employed to combat it, and the resources that have been made available for that purpose.
The US government has provided anti-money laundering support to more than 100 countries. But “Halting the introduction and circulation of criminally generated proceeds in the financial system, and, ultimately, depriving criminals from using illicit wealth remains a challenge,” the CRS report said. See Anti-Money Laundering: An Overview for Congress, March 1, 2017.
Other new and updated reports from the Congressional Research Service include the following.
The Scalia Vacancy in Historical Context: Frequently Asked Questions, March 1, 2017
Majority, Concurring, and Dissenting Opinions by Judge Neil M. Gorsuch, March 1, 2017
Safe Drinking Water Act (SDWA): A Summary of the Act and Its Major Requirements, updated March 1, 2017
Federally Funded Academic Research Requirements: Background and Issues in Brief, February 28, 2017
An Overview of Recent Tax Reform Proposals, February 28, 2017
Independence of Federal Financial Regulators: Structure, Funding, and Other Issues, February 28, 2017
U.S.-Mexico Water Sharing: Background and Recent Developments, updated March 2, 2017
Russia: Background and U.S. Interests, March 1, 2017
DNA synthesis and export controls remain the primary regulatory safeguards against de novo production of harmful biological agents, yet governance frameworks lack the situational awareness and enforcement capacity to keep pace with rapidly falling technical barriers.
Called today to speak on behalf of U.S. science and technology, Dr. Jedidah Isler, astrophysicist, educator, strategist, policy-maker, and science communicator, will provide constructive, nonpartisan feedback to the House Committee’s hearing “American Global Competitiveness at 250: Legislative Proposals to Secure U.S. Technology Leadership.”
“Federal data and access to it is not a partisan issue. It is a people issue. Our country cannot achieve greatness without access to the data that measure what we value, who we are, and where we’re heading.”
The United States’ biosecurity governance system is structurally incapable of detecting and responding to certain classes of threats. U.S. biosecurity tools have not kept pace with technological advancements or a changing threat landscape.